The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...

Along with Nutley-based Eisai, several other New Jersey-based giants in the space have conducted layoffs over the past few ...

The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...

The 2024-25 Youth Basketball League concluded with Nizwa Club securing the championship title, while Salalah Club finished as ...

Health updates cover U.S. involvement in WHO meetings, UK approval of Moderna's RSV vaccine, a Texas measles outbreak, FDA ...

SciClone will develop and distribute Tasfygo in greater China but Eisai will retain worldwide rights outside the region.

The European Commission had requested the committee consider new data on the drug that became available after it had adopted its positive opinion.